PUBLICATION

Anticonvulsant effect of Sodium cyclamate and propylparaben on PTZ-induced seizures in zebrafish

Authors
Pisera-Fuster, A., Otero, S., Talevi, A., Bruno-Blanch, L., Bernabeu, R.
ID
ZDB-PUB-170125-3
Date
2017
Source
Synapse (New York, N.Y.)   71(4): e21961 (Journal)
Registered Authors
Keywords
none
MeSH Terms
  • Animals
  • Anticonvulsants/pharmacology*
  • Cyclamates/pharmacology*
  • Disease Models, Animal
  • Parabens/pharmacology*
  • Pentylenetetrazole/toxicity
  • Preservatives, Pharmaceutical/adverse effects
  • Preservatives, Pharmaceutical/pharmacology
  • Reaction Time/drug effects
  • Seizures/etiology
  • Seizures/physiopathology*
  • Sweetening Agents/adverse effects
  • Sweetening Agents/pharmacology
  • Toxicity Tests/methods
  • Zebrafish
PubMed
28118493 Full text @ Synapse
Abstract
Screening for novel anticonvulsant drugs requires appropriate animal seizure models. Zebrafish provide small, accessible and cost-efficient preclinical models applicable to high-throughput small molecule screening. Based in previous results in rodents, we have here examined the effects of artificial sweetener sodium cyclamate and antimicrobial agent sodium propylparaben on a model of PTZ-induced seizures in zebrafish. Sodium cyclamate reduced the bursts of hyperactivity, the spasms, increased the latency to spasms and the latency to seizure, while propylparaben increased the latency to spasms. The results show the potential of zebrafish to detect novel anticonvulsant compounds while they also demonstrate the ability of two commonly ingested chemical compounds to modify the seizure threshold when were administrated at low concentration.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping